Bill
Bill > S2032
RI S2032
RI S2032Prohibits an insurance company from imposing any cost-sharing requirements for any diagnostic or supplemental breast examinations.
summary
Introduced
01/09/2026
01/09/2026
In Committee
01/09/2026
01/09/2026
Crossed Over
Passed
Dead
Introduced Session
2026 Regular Session
Bill Summary
This act would prohibit an insurance company from imposing any cost-sharing requirements for any diagnostic or supplemental breast examinations. This act would take effect on January 1, 2027.
AI Summary
This bill, effective January 1, 2027, prohibits insurance companies, including those offering accident and sickness policies, nonprofit hospital and medical service corporations, and health maintenance organizations, from charging patients any out-of-pocket expenses, such as deductibles, coinsurance, or copayments, for diagnostic or supplemental breast examinations. Diagnostic breast examinations are defined as medically necessary tests used to investigate an abnormality found during screening or detected by other means, including mammography, MRI, or ultrasound. Supplemental breast examinations are defined as medically necessary screenings, such as MRI or ultrasound, performed when no abnormality is suspected but an individual has a higher risk due to personal or family medical history or other factors.
Committee Categories
Health and Social Services
Sponsors (10)
Sam Zurier (D)*,
Peter Appollonio (D),
Pam Lauria (D),
Melissa Murray (D),
Sue Sosnowski (D),
Brian Thompson (D),
David Tikoian (D),
Linda Ujifusa (D),
Lori Urso (D),
Bridget Valverde (D),
Last Action
Introduced, referred to Senate Health and Human Services (on 01/09/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://status.rilegislature.gov/ |
| BillText | https://webserver.rilegislature.gov/BillText26/SenateText26/S2032.pdf |
Loading...